Kamal Kamal Gadalla, Ph.D. - Publications

Affiliations: 
Tanta University 
Area:
Neuroscience

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Powers S, Likhite S, Gadalla KK, Miranda CJ, Huffenberger AJ, Dennys C, Foust KD, Morales P, Pierson CR, Rinaldi F, Perry S, Bolon B, Wein N, Cobb S, Kaspar BK, et al. Novel MeCP2 Gene Therapy is Effective in a Multicenter Study using Two Mouse Models of Rett Syndrome and is Safe in Non-human Primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 37481701 DOI: 10.1016/j.ymthe.2023.07.013  0.471
2014 Gadalla KK, Ross PD, Riddell JS, Bailey ME, Cobb SR. Gait analysis in a Mecp2 knockout mouse model of Rett syndrome reveals early-onset and progressive motor deficits. Plos One. 9: e112889. PMID 25392929 DOI: 10.1371/journal.pone.0112889  0.46
2013 Gadalla KK, Bailey ME, Spike RC, Ross PD, Woodard KT, Kalburgi SN, Bachaboina L, Deng JV, West AE, Samulski RJ, Gray SJ, Cobb SR. Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 18-30. PMID 23011033 DOI: 10.1038/Mt.2012.200  0.497
2011 Gadalla KK, Bailey ME, Cobb SR. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. The Biochemical Journal. 439: 1-14. PMID 21916843 DOI: 10.1042/BJ20110648  0.484
Show low-probability matches.